Approximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming changes at CVS that may make getting the drug harder and pricier. Scripta ...

People who have frequent nightmares appear to have a tripled risk of premature death, according to a new study.

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...

Sixty-three percent of patients starting on Novo Nordisk's Wegovy or Eli Lilly's Zepbound during the first quarter of 2024 ...

The effect of Novo Nordisk’s amycretin injections on body weight showed no signs of plateauing after 36 weeks, suggesting the ...

BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking ...

Novo on Sunday said full results from two late-stage trials of CagriSema - one in people with obesity or overweight, the ...

A federal judge plans to order the release of Kilmar Abrego Garcia, whose mistaken deportation has become a flashpoint in President Donald Trump’s immigration crackdown.

VANQUISH-1 and VANQUISH-2 Studies to Evaluate Subcutaneous VK2735 in Obese Adults with and without Type 2 Diabetes SAN DIEGO, June 25, 2025 /PRNewswire/ ...

"Lilly’s release of Zepbound single-dose vials at a lower, self-pay-only price was groundbreaking and reflects the patient-centric model upon which Ro was founded," said the DTC telehealth start ...